Related Experiment Videos

Lisa Bohlen1, Raphael Jeker1, Thomas Fehr1

  • 1Innere Medizin, Kantonsspital Graubünden.

Praxis
|January 9, 2020
PubMed

Insights

Hypercalcemia, or high blood calcium, presents with neurological and cardiovascular symptoms. Prompt treatment and identifying the underlying cause, such as parathyroid hormone dysfunction, are crucial for patient management.

Area of Science:

  • Endocrinology
  • Nephrology
  • Internal Medicine

Background:

  • Hypercalcemia is defined as an albumin-corrected calcium level greater than 2.6 mmol/l.
  • Symptoms manifest primarily in neurological-psychiatric and cardiovascular systems.
  • Severe, symptomatic hypercalcemia constitutes a medical emergency requiring immediate intervention.

Purpose of the Study:

  • To define hypercalcemia and its clinical manifestations.
  • To outline the urgent management of severe hypercalcemia.
  • To categorize hypercalcemia based on underlying pathophysiology for diagnostic guidance.

Main Methods:

  • Review of pathophysiology and clinical presentation of hypercalcemia.
  • Classification of hypercalcemia into four main etiological groups.
  • Emphasis on diagnostic approaches including medical history and laboratory tests.

Main Results:

  • Hypercalcemia is associated with significant neurological and cardiovascular morbidity.
  • Effective management necessitates both immediate treatment and etiological diagnosis.
  • The four pathophysiological groups include parathyroid hormone dysfunction, vitamin D metabolism disturbances, bone metabolism disorders, and impaired renal calcium excretion.

Conclusions:

  • Accurate diagnosis of the underlying cause is essential for effective hypercalcemia treatment.
  • A systematic approach based on pathophysiology aids in identifying the etiology.
  • Prompt recognition and management of hypercalcemia are critical for preventing severe complications.

Related Concept Videos